CytoMed Therapeutics Limited Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes
CytoMed Therapeutics Limited (GDTC) reported Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes of -SGD 2.56 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges · last filed 2026-03-31
SGD
| Period end | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 12 month |
|---|---|
| 2025-12-31 | -2.56M SGD 20-F · filed 2026-03-31 |
| 2024-12-31 | -1.65M SGD 20-F · filed 2026-03-31 |
| 2023-12-31 | 4.66M SGD 20-F · filed 2026-03-31 |
| 2022-12-31 | -903.00K SGD 20-F · filed 2025-04-28 |
| 2021-12-31 | 1.64M SGD 20-F · filed 2024-04-22 |
| 2020-12-31 | 521.02K SGD 20-F · filed 2023-05-01 |
USD
| Period end | Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes 12 month |
|---|---|
| 2025-12-31 | -$1.99M 20-F · filed 2026-03-31 |
| 2024-12-31 | -$1.21M 20-F · filed 2025-04-28 |
| 2023-12-31 | $3.53M 20-F · filed 2024-04-22 |
| 2022-12-31 | -$673.68K 20-F · filed 2023-05-01 |